(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-3.32%) $1.920
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
-0.29% NOK 34.00
@ NOK34.00
Utstedt: 26 apr 2024 @ 09:04
Avkastning: 0.00%
Forrige signal: apr 25 - 16:13
Forrige signal:
Avkastning: -0.29 %
Live Chart Being Loaded With Signals
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics...
Stats | |
---|---|
Dagens volum | 4 319.00 |
Gjennomsnittsvolum | 80 958.00 |
Markedsverdi | 592.72M |
EPS | NOK0.390 ( 2023-11-01 ) |
Neste inntjeningsdato | ( NOK0 ) 2024-05-31 |
Last Dividend | NOK0.998 ( 2010-04-13 ) |
Next Dividend | NOK0 ( N/A ) |
P/E | 28.81 |
ATR14 | NOK0.800 (2.35%) |
Volum Korrelasjon
Navamedic ASA Korrelasjon
10 Mest positive korrelasjoner | |
---|---|
NORSE.OL | 0.895 |
SMOP.OL | 0.871 |
NTEL.OL | 0.871 |
TOM.OL | 0.868 |
ENDUR.OL | 0.839 |
XXL.OL | 0.838 |
KIT.OL | 0.832 |
SNI.OL | 0.826 |
BORR.OL | 0.815 |
AYFIE.OL | 0.813 |
10 Mest negative korrelasjoner | |
---|---|
AKBM.OL | -0.895 |
ODL.OL | -0.895 |
SCATC.OL | -0.893 |
SBX.OL | -0.87 |
OKEA.OL | -0.858 |
VOLUE.OL | -0.857 |
PHO.OL | -0.854 |
FRO.OL | -0.852 |
TRVX.OL | -0.846 |
XPLRA.OL | -0.842 |
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Navamedic ASA Korrelasjon - Valuta/Råvare
Navamedic ASA Økonomi
Annual | 2023 |
Omsetning: | NOK512.00M |
Bruttogevinst: | NOK199.05M (38.88 %) |
EPS: | NOK0 |
FY | 2023 |
Omsetning: | NOK512.00M |
Bruttogevinst: | NOK199.05M (38.88 %) |
EPS: | NOK0 |
FY | 2022 |
Omsetning: | NOK382.14M |
Bruttogevinst: | NOK163.52M (42.79 %) |
EPS: | NOK1.750 |
FY | 2021 |
Omsetning: | NOK278.44M |
Bruttogevinst: | NOK111.74M (40.13 %) |
EPS: | NOK0.00774 |
Financial Reports:
No articles found.
Navamedic ASA Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
NOK0 (N/A) |
NOK0 (N/A) |
NOK0 (N/A) |
NOK0 (N/A) |
NOK0 (N/A) |
NOK0 (N/A) |
NOK0 (N/A) |
NOK0 (N/A) |
NOK0 (N/A) |
NOK0 (N/A) |
First Dividend | NOK0.998 | 2010-04-13 |
Last Dividend | NOK0.998 | 2010-04-13 |
Next Dividend | NOK0 | N/A |
Payout Date | 2010-04-27 | |
Next Payout Date | N/A | |
# dividends | 1 | -- |
Total Paid Out | NOK0.998 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 1.02 | -- |
Div. Sustainability Score | 5.91 | |
Div.Growth Potential Score | 0.831 | |
Div. Directional Score | 3.37 | -- |
Year | Amount | Yield |
---|---|---|
2010 | NOK0.998 | 17.80% |
2011 | NOK0 | 0.00% |
2012 | NOK0 | 0.00% |
2013 | NOK0 | 0.00% |
2014 | NOK0 | 0.00% |
2015 | NOK0 | 0.00% |
2016 | NOK0 | 0.00% |
2017 | NOK0 | 0.00% |
2018 | NOK0 | 0.00% |
2019 | NOK0 | 0.00% |
2020 | NOK0 | 0.00% |
2021 | NOK0 | 0.00% |
2022 | NOK0 | 0.00% |
2023 | NOK0 | 0.00% |
2024 | NOK0 | 0.00% |
With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
ALNG.OL | Dividend King | 2023-11-27 | Quarterly | 2 | 6.60% | 7.04 |
OKEA.OL | Dividend Knight | 2023-12-01 | Quarterly | 3 | 5.65% | 6.86 |
SALM.OL | Dividend Knight | 2023-06-09 | Annually | 17 | 2.80% | 4.97 |
BWLPG.OL | Dividend Knight | 2023-11-17 | Quarterly | 11 | 1.68% | 4.46 |
ELK.OL | Dividend Knight | 2023-05-02 | Annually | 6 | 6.64% | 4.31 |
BWO.OL | Dividend Knight | 2023-11-20 | Quarterly | 14 | 0.87% | 3.96 |
ATEA.OL | Dividend Knight | 2023-11-20 | Annually | 16 | 2.97% | 3.45 |
HAFNI.OL | Dividend Knight | 2023-11-23 | Semi-Annually | 5 | 1.18% | 3.31 |
AKER.OL | Dividend Knight | 2023-11-07 | Semi-Annually | 20 | 2.99% | 3.13 |
AUSS.OL | Dividend Knight | 2023-05-26 | Annually | 17 | 3.23% | 2.93 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.00752 | 1.500 | 9.85 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.00735 | 1.200 | 9.76 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0175 | 1.500 | -0.916 | -1.374 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.111 | 0.800 | 9.44 | 7.56 | [1 - 3] |
quickRatioTTM | 0.469 | 0.800 | -1.948 | -1.558 | [0.8 - 2.5] |
cashRatioTTM | 0.201 | 1.500 | 9.99 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.287 | -1.500 | 5.22 | -7.83 | [0 - 0.6] |
interestCoverageTTM | 2.30 | 1.000 | -0.260 | -0.260 | [3 - 30] |
operatingCashFlowPerShareTTM | -0.0520 | 2.00 | -0.0173 | -0.0346 | [0 - 30] |
freeCashFlowPerShareTTM | -0.180 | 2.00 | -0.0898 | -0.180 | [0 - 20] |
debtEquityRatioTTM | 0.675 | -1.500 | 7.30 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.378 | 1.000 | 7.03 | 7.03 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0404 | 1.000 | -1.192 | -1.192 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | -0.00595 | 1.000 | -1.144 | -1.144 | [0.2 - 2] |
assetTurnoverTTM | 0.977 | 0.800 | 6.82 | 5.46 | [0.5 - 2] |
Total Score | 5.91 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 152.06 | 1.000 | 10.00 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0175 | 2.50 | -0.589 | -1.374 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -0.180 | 2.00 | -0.0598 | -0.180 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -0.0520 | 2.00 | -0.0173 | -0.0346 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 1.751 | 1.500 | 1.657 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | -0.00175 | 1.000 | -2.54 | 0 | [0.1 - 0.5] |
Total Score | 0.831 |
Navamedic ASA
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic acidemia/propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases and renal diseases, fat metabolism, malnutrition, and ketogenic diet. In addition, the company provides consumer health products consisting of non-prescription drugs and health care products for pain relief, cough and cold, gastro, women's health, and others primarily through pharmacies and drugstores; specialty pharmaceutical products in various therapeutic areas comprising dermatology, wound care, women's health, urology, and obesity; and branded generics, including cardiology products and antibiotics. It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004. Navamedic ASA was incorporated in 2002 and is headquartered in Oslo, Norway.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.